Clindataceutics Private Limited, a active private limited company, was established on 22 February 2018 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U33100TG2018PTC122446. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Employing 6 professional, Its leadership includes Naresh Namani (Director), Suresh Azmeera (Director). Past directors included Swathi Sandanala, Suresh Azmeera, Azmeera Ramesh. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Plot No:28,H.No:1-30-588/1,Sivalayam Sivanagar,Khanajiguda,Alwal, Hyderabad, Telangana, 500010.
U33100TG2018PTC122446
122446
22 February 2018
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Clindataceutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naresh Namani | Director | 22 Feb 2018 | Current |
| Suresh Azmeera | Director | 24 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Aug 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Clindataceutics Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.12% decrease. The company also saw a substantial fall in profitability, with a 215.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 215.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Clindataceutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Clindataceutics has a workforce of 6 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Clindataceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clindataceutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Clindataceutics Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
The activity Clindataceutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was completed.
The activity Suresh Azmeera was appointed as a Director was appointed as a Director on 24 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
The activity Naresh Namani was appointed as a Director was appointed as a Director on 22 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
Progress on Clindataceutics Private Limited was registered on 22 Feb 2018 with Roc Hyderabad & aged 7 years 9 months as per MCA records. was documented.
The CIN of Clindataceutics Private Limited is U33100TG2018PTC122446.
Clindataceutics Private Limited is headquartered at Plot No:28,H.No:1-30-588/1,Sivalayam Sivanagar,Khanajiguda,Alwal, Hyderabad, Telangana, 500010.
Clindataceutics Private Limited was incorporated on 22 February 2018.
The current directors of Clindataceutics Private Limited are
The primary industry of Clindataceutics Private Limited is Pharma.
Clindataceutics Private Limited is unlisted.
The authorized capital of Clindataceutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX